HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Fernandez-Mejia Selected Research

Biotin (Vitamin H)

1/2017Pharmacological Effects of Biotin in Animals.
1/2016Dietary Biotin Supplementation Modifies Hepatic Morphology without Changes in Liver Toxicity Markers.
10/2015Effects of Biotin Supplementation in the Diet on Adipose Tissue cGMP Concentrations, AMPK Activation, Lipolysis, and Serum-Free Fatty Acid Levels.
4/2012Effects of biotin deficiency on pancreatic islet morphology, insulin sensitivity and glucose homeostasis.
10/2010Pharmacological concentrations of biotin reduce serum triglycerides and the expression of lipogenic genes.
10/2009Biotin deficiency and biotin excess: effects on the female reproductive system.
5/2006Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia.
7/2005Pharmacological effects of biotin.
2/2004Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Fernandez-Mejia Research Topics

Disease

4Biotin deficiency
04/2012 - 07/2005
3Insulin Resistance
01/2021 - 10/2010
2Hyperglycemia
01/2016 - 07/2005
2Hyperlipidemias (Hyperlipidemia)
10/2015 - 07/2005
2Hypertriglyceridemia
10/2010 - 05/2006
1Hypertension (High Blood Pressure)
01/2017
1Dyslipidemias (Dyslipidemia)
10/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2013
1Glucose Intolerance
07/2005
1Hypoglycemia (Reactive Hypoglycemia)
07/2005
1Type 2 Diabetes Mellitus (MODY)
02/2004

Drug/Important Bio-Agent (IBA)

9Biotin (Vitamin H)FDA Link
01/2017 - 02/2004
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 07/2005
3Insulin (Novolin)FDA Link
04/2012 - 07/2005
2Triglycerides (Triacylglycerol)IBA
10/2013 - 05/2006
1OsteocalcinIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
04/2012
1Glucagon (Glukagon)FDA Link
04/2012
1Messenger RNA (mRNA)IBA
10/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2009
1EnzymesIBA
07/2005
1VitaminsIBA
07/2005
1GlucokinaseIBA
07/2005
1PhosphoenolpyruvateIBA
07/2005
1Insulin ReceptorIBA
07/2005
1N 30IBA
02/2004

Therapy/Procedure

1Therapeutics
07/2005